Thrombospondin-1 Inhibits Nitric Oxide Signaling via CD36 by Inhibiting Myristic Acid Uptake
Open Access
- 1 May 2007
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (21) , 15404-15415
- https://doi.org/10.1074/jbc.m701638200
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- The association between CD36 and Lyn protein tyrosine kinase is mediated by lipidBiochemical and Biophysical Research Communications, 2006
- Peptides modified by myristoylation activate eNOS in endothelial cells through Akt phosphorylationBritish Journal of Pharmacology, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Myristic Acid Stimulates Endothelial Nitric-oxide Synthase in a CD36- and an AMP Kinase-dependent MannerJournal of Biological Chemistry, 2005
- Thrombospondin sequence motif (CSVTCG) is responsible for CD36 bindingPublished by Elsevier ,2004
- Discovery of Some of the Biological Effects of Nitric Oxide and its Role in Cell SignalingBioscience Reports, 2004
- Recognition of the N-terminal Modules of Thrombospondin-1 and Thrombospondin-2 by α6β1 IntegrinJournal of Biological Chemistry, 2003
- Role of c-Fyn in FGF-2-Mediated Tube-like Structure Formation by Murine Brain Capillary Endothelial CellsBiochemical and Biophysical Research Communications, 2002
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001
- Labeling of adipocyte membranes by sulfo-N-succinimidyl derivatives of long-chain fatty acids: Inhibition of fatty acid transportThe Journal of Membrane Biology, 1991